Watch Ticker

Black Diamond Therapeutics, Inc. Common Stock

Go to Black Diamond Therapeutics, Inc. Common Stock Website

$2.70

-0.13 (-4.59%)

Live

Previous Close

$2.73

Day Range

$2.69 - $2.87

Previous Day Range

$2.6 - $2.86

Market Cap

$160.9 million USD

Day Vol.

765841

Previous Day Vol.

751938

Currency

USD

Primary Exchange

Nasdaq

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic t...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Jesterai - Clarus (CLAR) Q2 Loss Beats Estimates

Clarus reported Q2 2025 earnings with mixed results, narrowly beating analyst expectations on revenue and adjusted net loss per share, but experiencing revenue decline and ongoing profitability challenges.

Related tickers: CLAR, BDTX.

Read Full Article

N/A - Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy

Servier and Black Diamond Therapeutics have announced a global licensing agreement for BDTX-4933, a targeted oncology therapy in Phase 1 development. Servier will lead the development and commercialization of the therapy, with Black Diamond receiving an upfront payment and potential milestone and royalty payments.

Related tickers: BDTX.

Read Full Article

Trending Tickers

Please sign in to view